Study of Itacitinib in Combination With Docetaxel in Subjects With Non-Small Cell Lung Cancer

NCT02257619 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
9
Enrollment
INDUSTRY
Sponsor class

Stopped Sponsor decision to not initiate part 2 due to slow enrollment and competing trials.

Conditions

Interventions

Sponsor

Incyte Corporation